NCT06205342View on ClinicalTrials.gov

Safety and Efficacy of Mesenchymal Stem Cells Associated With Chronic Pancreatitis Pain

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

July 17, 2024

Primary Completion Date

June 1, 2027

Study Completion Date

June 1, 2028

Conditions
Chronic PancreatitisChronic Pain
Interventions
DRUG

Mesenchymal Stem Cells

Autologous bone marrow derived MSCs

OTHER

Other: Placebo

Control

Trial Locations (1)

29425

RECRUITING

Medical University of South Carolina, Charleston

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Medical University of South Carolina

OTHER